ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Hepatoprotective effect of Typhaneoside on non-alcoholic fatty liver disease via farnesoid X receptor in vivo and in vitro

Zheng, Yi; Zhao, Jian; Miao, Deyu; Xu, Tingting; Wang, Liziniu; Liu, Changhui; Gao, Yong; Yu, Lili; Shen, Chuangpeng*广东工业大学; 广州中医药大学; 1
Biomedicine and Pharmacotherapy2023-8DOI: 10.1016/j.biopha.2023.114957
1被引9阅读
引用收藏
分享

摘要

Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent health issues. The improvement of NAFLD is related to the activation of the farnesoid X receptor (FXR). Typhaneoside (TYP) is the main component of Typha orientalis Presl, which plays a positive role in the resistance of glucose and lipid metabolism disorders. This study aims to investigate the alleviative effect and the underlying mechanism of TYP on OAPA-induced cells and high-fat-diet (HFD)-induced mice with disorders of glucose and lipid metabolism, inflammation, oxidative stress and lower thermogenesis through FXR signaling. All the serum lipid, body weight, oxidative stress and inflammatory levels of WT mice were significantly increased after HFD administration. These mice were pre-sented with pathological injury, liver tissue attenuation, energy expenditure, insulin resistance, and impaired glucose tolerance. These above-mentioned changes in HFD-induced mice were remarkably reversed by TYP, which improved HFD-induced energy expenditure, oxidative stress, inflammation, insulin resistance, and lipid accumulation in a dose-dependent manner by activating the expression of FXR. Furthermore, using a high throughput drug screening strategy based on fluorescent reporter genes, we found that TYP functions as a natural agonist of FXR.TYP-mediated FXR activation also significantly repressed TG hyperaccumulation in mouse pri-mary Hepatocytes (MPHs). However, these beneficial effects of TYP were not observed in FXR-/-MPHs. Overall, activation of the FXR pathway by TYP is related to the improvement of metabolic parameters, such as blood glucose, lipid accumulation, insulin resistance, inflammation, oxidative stress and energy expenditure in vitro and in vivo.

学科与关键词

关键词
FXRNAFLDTyphaneosideGlucose homeostasisLipid homeostasisThermogenesis
相关
加载中…
  • Hepatic Clstn3 Ameliorates Lipid Metabolism Disorders in High Fat Diet-Induced NAFLD through Activation of FXR
    Guo, Jingyi; Huang, Shangyi; Yi, Qincheng; Liu, Naihua; Cui, Tianqi; Duan, Siwei; Chen, Jiabing; Li, Jiayu; Li, Jun; Wang, Lei*; Gao, Yong*; Nie, Guangning*ACS OMEGA, 2023, 8(29): 26158-26169.
  • Discovery of a tricyclic farnesoid X receptor agonist HEC96719, a clinical candidate for treatment of non-alcoholic steatohepatitis
    Cao, Shengtian; Yang, Xinye; Zhang, Zheng; Wu, Junwen; Chi, Bo; Chen, Hong; Yu, Jianghong; Feng, Shanshan; Xu, Yulin; Li, Jing; Zhang, Yingjun; Wang, Xiaojun*; Wang, Yan*European Journal of Medicinal Chemistry, 2022, 230: 114089.被引 9
  • The roles and interaction of FXR and PPARs in the pathogenesis of nonalcoholic fatty liver disease
    Li, Yu-Yuan; Cao, Chuang-Yu; Zhou, You-lian; Nie, Yu-Qiang; Cao, Jie; Zhou, Yong-Jian*Arab Journal of Gastroenterology, 2020, 21(3): 162-168.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomedicine and Pharmacotherapy
发表日期
2023-08
卷期
第 164 卷
页码
114957
DOI
10.1016/j.biopha.2023.114957
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province [2023A1515012618]; National Natural Science Foundation of China [82160891, 82174032]

作者

  • Z

    Zheng, Yi (第一作者)

    1 · guangzhou univ chinese med

  • Z

    Zhao, Jian

    1 · guangzhou univ chinese med

查看全部 9 位作者收起作者
  • M

    Miao, Deyu

    1 · guangzhou univ chinese med

  • X

    Xu, Tingting

    1 · guangzhou univ chinese med

  • W

    Wang, Liziniu

    guangzhou univ chinese med

  • L

    Liu, Changhui

    guangzhou univ chinese med

  • G

    Gao, Yong

    guangzhou univ chinese med

  • Y

    Yu, Lili

    guangdong univ technol

  • S

    Shen, Chuangpeng (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417